The NADPH oxidase inhibitor apocynin suppresses AOPP-induced microglial pyroptosis via the ROS-dependent MAPK-NF-κB signaling pathway and NLRP3-GSDMD pathway following spinal cord injury (SCI), thereby improving SCI prognosis. Here, GSDMD is linked to spinal cord injury.